3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
9
Colorectal Neoplasms
7
Rectal Neoplasms
5
Colorectal Cancer Metastatic
5
Ovarian Neoplasms
4
Neoplasms
4
Lung Neoplasms
3
Colonic Neoplasms
3
Uveal Melanoma
2
Melanoma
2
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Somatostatinoma
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neurofibromatosis 2
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Macular Degeneration
1
Interventions
Platinum
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Cisplatin
2
Biopsy
2
1,2-diaminocyclohexaneplatinum II citrate
2
rocakinogene sifuplasmid
1
fludarabine phosphate
1
fludarabine
1
durvalumab
1
alovudine
1
aldesleukin
1
Vaccines, Synthetic
1
VGX-3100
1
Sonazoid
1
Respiratory Function Tests
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiosurgery
1
Prochlorperazine
1
Positron-Emission Tomography
1
Ondansetron
1
O(6)-codeine methyl ether
1
Meperidine
1
Magnetic Resonance Imaging
1
MEDI0457
1
Loperamide
1
Interleukin-2
1
Innovar
1
Indomethacin
1
Immunoglobulin G
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Vulvar Neoplasms
×
aflibercept
×
Clear all
No trials found.